NURON BIOTECH
Nuron Biotech Inc. develops specialty biologics and vaccines. Its product pipeline comprises central nervous system products, such as NU100, a recombinant human interferon beta-1b for the treatment of relapsing remitting multiple sclerosis; wound healing products, including NU200, a recombinant human epidermal growth factor product for healing diabetic foot ulcers and burns; and HibTITER, a conjugate vaccine. The company was founded in 2010 and is based in Exton, Pennsylvania.
NURON BIOTECH
Industry:
Biotechnology Health Care Medical
Founded:
2010-01-01
Address:
Exton, Pennsylvania, United States
Country:
United States
Website Url:
http://www.nuronbiotech.com
Total Employee:
11+
Status:
Active
Contact:
610-968-6700
Total Funding:
102.71 M USD
Technology used in webpage:
Amazon Amazon Virginia Region Amazon S3 CDN Amazon Elastic Load Balancing Amazon ELB North Virginia
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
ZS Pharma
ZS Pharma develops ion trap therapies for the treatment of life-threatening medical conditions such as hyperkalemia and liver diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
HealthCare Royalty Partners
HealthCare Royalty Partners investment in Private Equity Round - Nuron Biotech
HealthCare Royalty Partners
HealthCare Royalty Partners investment in Private Equity Round - Nuron Biotech
Official Site Inspections
http://www.nuronbiotech.com
- Host name: ec2-3-219-145-25.compute-1.amazonaws.com
- IP address: 3.219.145.25
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Nuron Biotech"
Nuron Biotech - Crunchbase Company Profile & Funding
Nuron Biotech develops vaccines and specialty biologics for the prevention and treatment of infectious and neurodegenerative diseases.See details»
Nuron Biotech Inc - Company Profile and News - Bloomberg …
Nuron Biotech is a biotechnology company. The Company develops therapeutic biologics and vaccines for Multiple Sclerosis.See details»
Nuron acquires Pfizer's meningitis vaccine | Fierce Pharma
Dec 11, 2012 · Startup Nuron Biotech acquired from Pfizer ($PFE) a vaccine to protect against meningitis, sepsis and pneumonia for an undisclosed amount. Meningitec, registered in 23 …See details»
Organization | Nuron Biotech
Organization Overview. First Clinical Trial. 2011 NCT01464905. First Marketed Drug. None First NDA Approval. None Last Known Activity ... Nuron Biotech Inc. Active Ingredients. Drugs in …See details»
Nuron Biotech - Products, Competitors, Financials, Employees ...
Nuron Biotech's lead drug candidate, NU100 (interferon beta-1b), is a new chemical entity currently in Phase 3 for patients with multiple sclerosis. Nuron's vaccine brands include …See details»
Nuron Biotech - Contacts, Employees, Board Members
Nuron Biotech develops vaccines and specialty biologics for the prevention and treatment of infectious and neurodegenerative diseases.See details»
Nuron Biotech - Funding, Financials, Valuation & Investors
Nuron Biotech develops vaccines and specialty biologics for the prevention and treatment of infectious and neurodegenerative diseases.See details»
Nuron Biotech - VentureRadar
Nuron Biotech's lead drug candidate, NU100 (interferon beta-1b), is a new chemical entity currently in Phase 3 for patients with multiple sclerosis. Nuron's vaccine brands include …See details»
Nuron Biotech, Inc. (Nuron Biotech, Inc.) - 药物管线_专利_临床试 …
了解Nuron Biotech, Inc. (Nuron Biotech, Inc.)公司的药物管线，治疗领域，技术平台，以及它的6项临床试验, 1篇新闻，疾病领域:感染，技术平台:结合疫苗，预防性疫苗，药 …See details»
Nuron Biotech bags $80M deal to back vaccines ... - Fierce Biotech
Dec 20, 2012 · This morning Nuron Biotech joined the parade, announcing an $80 million deal designed to boost its work expanding a portfolio of vaccines while pushing ahead on a late …See details»
Nuron Biotech Raises $80 Million - BioSpace
EXTON, Pa. -- December 20, 2012 -- Nuron Biotech, Inc., a specialty biologics and vaccines company, today announced the closing of an $80 million financing provided by new investor …See details»
Nuron Company Profile 2024: Valuation, Funding & Investors
The company's platform automates data organization, report creation, experiment design, data analysis, and decision-making, enabling scientists and engineers in various industries to …See details»
Nuron Biotech Raises $80 Million from HealthCare Royalty Partners
Dec 20, 2012 · Nuron Biotech, Inc., a specialty biologics and vaccines company, today announced the closing of an $80 million financing provided by new investor HealthCare …See details»
Nuron Biotech Announces Appointment of New Management
Oct 17, 2013 · EXTON, Pa.-- (BUSINESS WIRE)--Nuron Biotech Inc., a revenue-generating vaccines and specialty biologics company, today announced the election of Dr. Warren D. …See details»
Nuron Biotech - Updates, News, Events, Signals & Triggers
Nuron Biotech develops vaccines and specialty biologics for the prevention and treatment of infectious and neurodegenerative diseases.See details»
Nuron Biotech Buys Pfizer Inc.'s Preventive Vaccine Meningitec
Dec 10, 2012 · EXTON, Pa.-- (BUSINESS WIRE)-- Nuron Biotech Inc., a specialty biologics and vaccines company, today announced it has acquired from Pfizer Inc. Meningitec™, which is a …See details»
Nuron Biotech to Develop Long-acting Version of Proprietary …
May 27, 2011 · EXTON, Pa.-- (BUSINESS WIRE)--Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has secured an exclusive option and license …See details»
Nuron Biotech Expands Portfolio With Exclusive, Worldwide …
Apr 12, 2012 · About Nuron Biotech. Nuron Biotech is developing novel biologics and vaccines for the prevention and treatment of chronic neurodegenerative and infectious diseases.See details»
Nuron Biotech Raises $80 Million from HealthCare Royalty Partners
Dec 21, 2012 · Nuron Biotech’s lead drug candidate, NU100 (interferon beta-1b), is a new chemical entity currently in Phase 3 for patients with multiple sclerosis. Nuron’s vaccine …See details»
Nuron Biotech Expands Portfolio With License of Therapeutic and ...
Mar 8, 2012 · EXTON, Pa.-- (BUSINESS WIRE)--Nuron Biotech Inc. today announced it has acquired an exclusive license of technology and product rights relating to Chimigen® multi …See details»